| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.003 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.31 | 0.004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.086 | 0.005 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.084 | 0.006 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.007 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.078 | 0.008 |